Core Laboratories Inc. (CLB)

Core Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	29.57	30.39	32.15	37.03	39.32	20.22
Depreciation & Amortization	14.7	14.65	14.95	15.78	17.16	18.52
Stock-Based Compensation	8.01	7.14	3.76	13.97	7.76	19.09
Other Adjustments	1.31	-0.62	-2.35	-13.22	5.4	-0.69
Change in Receivables	6	-4.95	-3.61	-2.62	-10.08	-13.52
Changes in Inventories	-0.54	2.64	9.37	-12.98	-14.86	-4.55
Changes in Accounts Payable	0.35	0.48	0.52	-12.88	15.37	6.57
Changes in Accrued Expenses	-4.17	-2.71	2.53	-0.38	-1.3	-8.76
Changes in Unearned Revenue	-5.06	-3.78	4.58	-1.19	-1.82	2.31
Changes in Other Operating Activities	-10.04	-6.21	-5.5	1.26	-12.33	-2.61
Operating Cash Flow	34.34	37.03	56.39	24.79	24.96	36.58
Operating Cash Flow Growth	-40.30%	-34.33%	127.47%	-0.67%	-31.77%	-36.79%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-15.9	-14.59	-13.03	-10.58	-10.22	-13.54
Sale of Property, Plant & Equipment	3.28	3.02	1.74	0.49	1.89	0.68
Purchases of Intangible Assets	-	-0.15	0.02	0.07	-0.03	-0.32
Proceeds from Sale of Intangible Assets	0.01	-	-	-	-	-
Purchases of Investments	-	-	-	-	3.68	-
Proceeds from Sale of Investments	-	0.78	2.78	3.38	-	1.36
Cash Acquisitions	-	-1.24	-	-	-	-
Proceeds from Business Divestments	-	-	-	-	0.24	0.87
Other Investing Activities	6.83	9.95	2.1	-	0.58	0.73
Investing Cash Flow	-6.39	-2.23	-6.39	-6.65	-3.86	-10.22

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	101	48	44	202	116	155
Long-Term Debt Repaid	-110	-63	-82	-211	-131	-226
Net Long-Term Debt Issued (Repaid)	-9	-15	-38	-9	-15	-71
Issuance of Common Stock	-	-	-	-	-	60
Repurchase of Common Stock	-14.4	-12.43	-5.31	-2.2	-3.9	-8.26
Net Common Stock Issued (Repurchased)	-14.4	-12.43	-5.31	-2.2	-3.9	51.74
Common Dividends Paid	-1.86	-1.87	-1.88	-1.87	-1.85	-1.83
Other Financing Activities	-0.26	-1.96	-0.78	-5.38	-2.62	-1.37
Financing Cash Flow	-27.23	-31.26	-45.96	-18.45	-23.38	-22.46

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	0.71	3.55	4.04	-0.31	-2.28	3.9

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	18.44	22.44	43.36	14.21	14.74	23.04
Free Cash Flow Growth	-58.81%	-48.24%	205.14%	-3.60%	-36.02%	-49.90%
FCF Margin	3.51%	4.26%	8.28%	2.79%	3.01%	4.90%
Free Cash Flow Per Share	0.39	0.48	0.91	0.30	0.31	0.49
Levered Free Cash Flow	-0.63	5.15	6.82	6.73	-3.54	-53.34
Unlevered Free Cash Flow	16.36	27.87	54.18	28.14	19.26	23.28

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Apr 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 23, 2026

Data Sources Report a data error